More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.15B
EPS
3.91
P/E ratio
14.4
Price to sales
2.45
Dividend yield
--
Beta
0.350816
Previous close
$45.44
Today's open
$46.66
Day's range
$44.89 - $47.14
52 week range
$42.62 - $87.12
show more
CEO
Ronald M. Lombardi
Employees
600
Headquarters
Tarrytown, NY
Exchange
New York Stock Exchange
Shares outstanding
47372166
Issue type
Common Stock
Consumer Staples
Consumer Products - Healthcare
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
GlobeNewsWire • 6 hours ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PRNewsWire • Jun 4, 2026

Is the Options Market Predicting a Spike in Prestige Consumer Stock?
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
Zacks Investment Research • Jun 1, 2026

Protect Your Investment: Contact Levi & Korsinsky About the Prestige Consumer Healthcare Inc. (PBH) Investigation
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) ("Prestige Consumer Healthcare Inc.") concerning potential violations of the federal securities laws. During the Q3 FY 2026 earnings call, CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57% adjusted gross margin in Q4.
Newsfile Corp • May 25, 2026

PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or “the Company”) (NYSE: PBH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
GlobeNewsWire • May 24, 2026

Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky
Prestige Consumer Healthcare shares fell sharply after Q4 earnings missed consensus estimates -- adjusted EPS came in at $1.23 versus the $1.39 expected, driven by unresolved supply-chain constraints management had assured investors were improving. NEW YORK, May 22, 2026 /PRNewswire/ -- Prestige Consumer Healthcare, Inc. (NYSE: PBH) investors suffered significant losses when the stock dropped after the Company reported Q4 fiscal 2026 earnings well below expectations, with adjusted EPS of $1.23 versus the $1.39 consensus estimate and revenue of $281.6 million falling short of forecasts.
PRNewsWire • May 22, 2026

Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 13, 2026, Prestige Consumer annou.
Business Wire • May 22, 2026

Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRESTIGE CONSUMER HEALTHCARE (PBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss.
Business Wire • May 22, 2026

Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On M.
Business Wire • May 22, 2026

INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC
ATLANTA, May 19, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Prestige Consumer Healthcare Inc. (“Prestige Consumer” or the “Company”) (NYSE: PBH) complied with federal securities laws. On May 13, 2026, Prestige Consumer reported fourth quarter and full year 2026 financial results revealing that revenues decreased by 5% compared to the fourth fiscal quarter 2025 and by 4.5% versus the prior fiscal year excluding the impact of foreign currency.
GlobeNewsWire • May 19, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Prestige Consumer Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.